Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» small cell lung cancer
small cell lung cancer
FDA starts speedy review of Amgen’s lung cancer BiTE therapy
Pharmaphorum
Thu, 12/14/23 - 09:34 am
Amgen
tarlatamab
small cell lung cancer
bispecifics
BiTE
solid tumors
Amgen Clinches Clinical Wins in SCLC and Colorectal Cancer
BioSpace
Fri, 08/4/23 - 12:30 pm
Amgen
oncology
colorectal cancer
small cell lung cancer
tarlatamab
Lumakras
Amgen's tarlatamab BiTEs at small cell lung cancer in brief readout
Fierce Biotech
Thu, 08/3/23 - 06:37 pm
Amgen
tarlatamab
small cell lung cancer
T-cells
FDA approves Legend Biotech’s IND application for lung cancer therapy trial
Clinical Trials Arena
Tue, 11/22/22 - 10:58 am
FDA
Legend Biotech
LB2102
small cell lung cancer
FDA Keeps Jazz’s SCLC Treatment on the Market Despite Failed Confirmatory Trial
BioSpace
Thu, 10/27/22 - 08:14 pm
Jazz Pharmaceuticals
FDA
Zepzelca
small cell lung cancer
FDA grants IND clearance for Phase I trials of Phanes’ cancer antibody
Clinical Trials Arena
Mon, 10/17/22 - 10:31 am
Phanes Therapeutics
PT217
FDA
small cell lung cancer
ESMO: Daiichi dazzles in lung cancer to dial up hopes for next ADC
Fierce Biotech
Mon, 09/12/22 - 10:43 am
ESMO
Daiichi Sankyo
DS-7300
small cell lung cancer
PhIII fail in overall survival measure clouds Ipsen's expansion plans for cancer drug Onivyde
Endpoints
Wed, 08/3/22 - 10:51 am
Ipsen
Onivyde
small cell lung cancer
clinical trials
Jazz recognizes less-common small cell lung cancer patients' needs with new online initiative
Fierce Pharma
Mon, 06/21/21 - 10:46 am
Jazz Pharmaceuticals
patient education
small cell lung cancer
Merck follows Bristol's suit, pulling Keytruda's SCLC nod. Is the FDA's accelerated approval reckoning finally here?
Fierce Pharma
Tue, 03/2/21 - 12:14 pm
Merck
Keytruda
FDA
small cell lung cancer
Opdivo
Bristol-Myers Squibb
Jazz's $1B SCLC drug fails combo trial, quashing hopes of quick full approval
Endpoints
Thu, 12/3/20 - 10:52 am
Jazz Pharmaceuticals
lurbinectedin
small cell lung cancer
clinical trials
Jazz Pharma’s $1B bet pays off with accelerated lung cancer approval
Endpoints
Tue, 06/16/20 - 10:37 am
Jazz Pharma
PharmaMar
FDA
Zepzelca
lurbinectedin
small cell lung cancer
Jazz targets US launch of SCLC drug after FDA grants fast review
Pharmaforum
Mon, 02/17/20 - 10:21 am
PharmaMar
Jazz Pharmaceuticals
FDA
small cell lung cancer
lurbinectedin
priority review
United Therapeutics Drug Flunks Small Cell Lung Cancer Clinical Trial
Xconomy
Mon, 02/3/20 - 10:34 am
United Therapeutics
clinical trials
Unituxin
small cell lung cancer
Merck’s Keytruda Shows Mixed Results in Lung Cancer Study
BioSpace
Tue, 01/7/20 - 10:30 am
Merck
Keytruda
small cell lung cancer
PharmaMar files for FDA approval of small cell lung cancer drug
Fierce Biotech
Tue, 12/17/19 - 10:37 am
PharmaMar
FDA
lurbinectedin
small cell lung cancer
Zepsyre has a path to market at last
EP Vantage
Mon, 08/19/19 - 10:55 am
PharmaMar
FDA
Zepsyre
small cell lung cancer
AstraZeneca’s Imfinzi gets FDA orphan drug status for small cell lung cancer
Pharmaceutical Business Review
Tue, 07/16/19 - 10:59 am
AstraZeneca
Imfinzi
FDA
small cell lung cancer
orphan drugs
Bristol-Myers details its failure on Checkmate 451, highlighting a bleak future for their checkpoint combo
Endpoints
Thu, 04/11/19 - 10:17 am
Bristol-Myers Squibb
Opdivo
Yervoy
small cell lung cancer
After ovarian cancer flop, PharmaMar's lurbinectedin makes the cut in small cell lung cancer
Endpoints
Mon, 03/25/19 - 10:19 am
PharmaMar
ovarian cancer
lurbinectedin
relapsed small cell lung cancer
small cell lung cancer
Pages
1
2
next ›
last »